Leuprolide Acetate Kit
Product Images NDC 47335-936

Product Visual Gallery

This gallery contains 17 technical images submitted to the FDA as part of the official labeling for Leuprolide Acetate (NDC 47335-936). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sun Pharmaceutical Industries, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Leuprolide-fig-1 (Leuprolide Fig 1)

Black-and-white illustration showing a hand holding a syringe filled with liquid. The syringe is positioned horizontally, and the hand grips the barrel and plunger, depicting the action of preparing or administering an injection.*

FDA Label Image

Leuprolide-fig-10 (Leuprolide Fig 10)

Illustration showing hands drawing liquid from a small vial into a syringe, demonstrating aseptic technique for medication preparation. The close-up detail highlights the vial's rubber stopper and the syringe needle inserted through it, consistent with preparation steps for injectable drugs.*

FDA Label Image

Leuprolide-fig-11 (Leuprolide Fig 11)

An instructional line drawing showing one hand holding a syringe and inserting the needle into the skin of the other hand, which is holding the injection site steady. The image illustrates a subcutaneous injection technique.*

FDA Label Image

Leuprolide-fig-12 (Leuprolide Fig 12)

An instructional line drawing showing one hand holding a syringe with the needle inserted into skin and an arrow indicating upward movement of the syringe, while the other hand applies a patch or covering on the skin. The illustration demonstrates a step in the injection or drug administration process, likely related to leuprolide acetate kit use.*

FDA Label Image

Leuprolide-fig-13 (Leuprolide Fig 13)

An instructional illustration showing a hand disposing of a syringe into a sharps container. The container has a circular opening on top designed for safe disposal of needles and syringes.*

FDA Label Image

Leuprolide-fig-2 (Leuprolide Fig 2)

Black and white instructional illustration showing hands being washed under a running faucet, with water flowing over the hands. The image emphasizes cleansing of hands, likely demonstrating proper hygiene or preparation steps related to the use of the medication kit.*

FDA Label Image

Leuprolide-fig-3 (Leuprolide Fig 3)

A black-and-white instructional illustration showing a finger lifting the tamper-evident cap off a glass vial, demonstrating how to open a vial, likely part of the use instructions for leuprolide acetate kit by Sun Pharmaceutical Industries, Inc.*

FDA Label Image

Leuprolide-fig-4 (Leuprolide Fig 4)

An instructional illustration showing close-up hands preparing an injection vial and syringe, suggesting the process of drawing medication into the syringe from the vial. The sketch style is simple and focused on demonstrating safe medication preparation technique.*

FDA Label Image

Leuprolide-fig-5 (Leuprolide Fig 5)

An instructional black-and-white line drawing depicting the process of removing the cap from a syringe. The illustration shows two hands: one holding the syringe and the other pulling a protective cap away from the syringe tip, indicated by directional arrows. This is likely part of preparation instructions for administering leuprolide acetate kit.*

FDA Label Image

Leuprolide-fig-6 (Leuprolide Fig 6)

An instructional illustration showing a hand holding a syringe with a needle, demonstrating the method of pulling back the plunger to draw fluid into the syringe. An arrow indicates the direction of the plunger movement away from the needle tip.*

FDA Label Image

Leuprolide-fig-7 (Leuprolide Fig 7)

A black and white illustration showing hands holding a syringe with a needle and a vial stopper, demonstrating part of a drug preparation or injection process. No visible text or branding is shown.*

FDA Label Image

Leuprolide-fig-8 (Leuprolide Fig 8)

An instructional black-and-white illustration showing a person using a syringe to withdraw medication from a vial. The image focuses on the hands holding the vial and syringe, demonstrating how to prepare an injection.*

FDA Label Image

Leuprolide-fig-9 (Leuprolide Fig 9)

An instructional line drawing showing a close-up of a hand holding a vial and inserting a needle or syringe into the vial's rubber stopper, likely demonstrating how to prepare or withdraw medication for use.*

FDA Label Image

Leuprolide-innercarton (Leuprolide Innercarton)

Packaging label for leuprolide acetate injection, 14 mg/2.8 mL (1 mg/0.2 mL) sterile injection vial. The label indicates a 2.8 mL multiple-dose vial for subcutaneous injection. Distributed by Sun Pharmaceutical Industries, Inc., with storage instructions and preservative details included. The label also features the Sun Pharma logo and a barcode.*

FDA Label Image

Leuprolide-label (Leuprolide Label)

Label for leuprolide acetate injection 14 mg/2.8 mL (1 mg/0.2 mL) in a 2.8 mL multiple-dose sterile injection vial, for subcutaneous injection. Distributed by Sun Pharmaceutical Industries, Inc., Cranbury, NJ, and manufactured by Sun Pharmaceutical Ind. Ltd., India. The label includes storage instructions, NDC 47335-936-40, and space for batch number and expiration date.*

FDA Label Image

Leuprolide-outercarton (Leuprolide Outercarton)

Leuprolide Acetate Injection 14 mg/2.8 mL (1 mg/0.2 mL) kit label displays product name, dosage form as injection for subcutaneous use, and identifies it as a 14 Day Patient Administration Kit. Label includes prescription status and Sun Pharmaceutical Industries, Inc. logo with NDC 47335-936-40.*

FDA Label Image

Leuprolide-structure (Leuprolide Structure)

Chemical structure of leuprolide acetate, shown as a linear peptide chain with labeled atoms and functional groups, including rings and side chains characteristic of the molecule.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.